What's your take on the unbelievable fall of this company? I always thought the platform was impressive and the clinical data thus far solid, but I don't have a science background. I am having a hard time understanding the amount of value the company has lost to a valuation literally below cash. That's not just poor management. It reflects the value and demand for the science. I wonder if ADXS were ever subject to a case study if it would be put in the category of a scam given more that $200 million has been poured into the company and it's evaporated, yet the company has always touted that the clinical trial data has been compelling.
Market Data 
Markets 
AI
